Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Investors to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ZBIO. Zenas […]